Form 4: Marimed Inc. COO Timothy Shaw Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
Marimed Inc.'s Chief Operating Officer, Timothy Shaw, reported the acquisition of 243,750 restricted stock units (RSUs) and a change in beneficial ownership of common stock.
Summary
- Timothy Shaw, the Chief Operating Officer of Marimed Inc., filed a Form 4 disclosing changes in his beneficial ownership of the company's securities.
- Shaw acquired 243,750 restricted stock units (RSUs) on November 29, 2024, which convert to common stock on a one-for-one basis.
- These RSUs will vest over a three-year period, with one-third vesting on the first anniversary of the grant date and one-sixth vesting every six months thereafter.
- The filing also indicates that Shaw directly owns 8,733,628 shares of common stock and indirectly owns 2,000,000 shares through the Shaw Family Trust.
- Shaw's spouse is the trustee of the Shaw Family Trust, which holds shares for the benefit of Shaw's children.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing, but the acquisition of RSUs by the COO is a positive sign of alignment with the company's future. The sentiment is therefore neutral to slightly positive.
Positives
- The acquisition of RSUs by the COO could be seen as a positive sign of his commitment to the company's future.
- The vesting schedule of the RSUs aligns the COO's interests with the long-term performance of the company.
Management Comments
- The reporting person disclaims beneficial ownership of the securities held by the Shaw Family Trust, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Industry Context
Form 4 filings are a standard part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders. This filing is typical for a company where executives are granted equity as part of their compensation.
Comparison to Industry Standards
- The vesting schedule of the RSUs, with one-third vesting after one year and one-sixth every six months thereafter, is a common practice in executive compensation packages.
- The use of a family trust to hold shares is also a common practice for estate planning and asset management purposes.
Stakeholder Impact
- The acquisition of RSUs by the COO could be viewed positively by shareholders as it aligns his interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | Date of the earliest transaction, the acquisition of 243,750 RSUs. |
| 12/02/2024 | Date of signature of the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Restricted Stock Units, RSU, Marimed Inc, MRMD, Timothy Shaw, Chief Operating Officer, Stock Options, Equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.